NORML | November 15, 2017 PHILADELPHIA, PA — Retail products marketed and sold online as CBD extracts are typically mislabeled with regard to their potency and ingredients, according to findings published in the Journal of the American Medical Association. A research team led by the University of Pennsylvania analyzed the contents of 84 CBD-infused products, produced by 31 different companies. Only 30 percent of the …
DEA Spokesman: Agency Not Going to ‘Break Down Door’ of Parents Administering CBD to their Children
In an interview with Indiana’s WTHR, Drug Enforcement Agency spokesperson Rusty Payne admitted that while parents giving CBD oil to their children are violating federal law, it is unlikely they will face federal prosecution for their actions. “WTHR: What would you tell the mom and dad who are buying this stuff and giving it to their kids because it helps …
FDA Sends Warning Letter to 4 CBD Companies Over Anti-Cancer Claims
The Food and Drug Administration has sent a warning letter to four CBD companies demanding that they stop making claims that their products “prevent, diagnose or cure cancer” without evidence to back their claims. Stanley Brothers Social Enterprises, the makers of Charlotte’s Web, are among the four companies to receive the letters, along with Greenroads Health, Natural Alchemist, and That’s …
FDA Issues Warning To CBD Companies
On November 1st, the U.S. Food and Drug Administration (FDA) published a press release addressing warning letters issued to four companies. The warning letters, sent to companies marketing cannabidiol (CBD) products with therapeutic claims, cites unsubstantiated claims about their products’ ability to treat or cure cancer and other diseases. A snippet of the warning letter issued to Greenroads According to …
Texas’ First MMJ Dispensary Set to Open in December
Texas’ first medical cannabis dispensary is slated to open in December and according to a Houston Public Media report, there are already around 150,000 patients in the state registered to access the program. Despite the high patient count, the program is of the limited variety, offering low-THC, high-CBD oils for patients with intractable epilepsy. Under the state’s Compassionate Use Program, …
Enforcement of Intellectual Property Rights for Cannabis Put to Test in Federal Court
A number of cannabis businesses have pursued federal intellectual property protection for their cannabis-related innovations, such as U.S. patents that protect novel cannabis plant varieties, growing methods, extraction methods, etc. Enforcement of such federal IP rights requires that the IP owner file suit in federal court asserting those rights against another cannabis company. However, given that cannabis is still illegal …
PA Approves First Two Cannabis Labs
According to a PennLive article, Pennsylvania’s Department of Health approved the first two cannabis laboratories for their medical cannabis program. ACT Laboratories of Pennsylvania LLC and Keystone State Testing LLC are the companies that were approved to perform analytical testing for safety and quality in cannabis products. Both laboratories expect to be operational before the end of 2017, according to …
Anti-Doping Agency Removes CBD from Prohibited List
The World Anti-Doping Agency has removed CBD from its prohibited substances list for 2018 and added synthetic cannabinoids, such as “Spice.” However, according to the 2018 Prohibited List summary, athletes subject to the organization’s testing might want to be sure their CBD products are tested and accurately labeled as THC remains prohibited. “Cannabidiol is no longer prohibited. Synthetic cannabidiol is …
Wisconsin Tribe Adopts CBD Program
The St. Croix Chippewa Indians of Wisconsin have adopted a “comprehensive control program” for hemp-derived CBD and announced plans to open businesses selling CBD products in states where it is allowed. Elmer J. Emery, a member of the St. Croix Tribal Council said the tribe plans on producing and distributing CBD products on its tribal lands in northwestern Wisconsin which …